From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson’s disease?
Parkinson’s disease is the second most prevalent neurodegenerative disorder worldwide. Clinically, it is characterized by severe motor complications caused by progressive degeneration of dopaminergic neurons. Current treatment is focused on mitigating the symptoms through the administration of levod...
Main Authors: | Rita Caridade Silva, Helena Sofia Domingues, António J Salgado, Fábio G Teixeira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=5;spage=933;epage=936;aulast=Silva |
Similar Items
-
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
by: Bárbara Mendes-Pinheiro, et al.
Published: (2019-11-01) -
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
by: Fábio G. Teixeira, et al.
Published: (2020-01-01) -
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
by: Michele d’Angelo, et al.
Published: (2020-07-01) -
Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
by: Helena Vilaça-Faria, et al.
Published: (2019-02-01) -
Treating Parkinson’s Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration
by: Bárbara Mendes-Pinheiro, et al.
Published: (2023-11-01)